Iradimed Corp (IRMD)

Finanzdaten der Iradimed Corp-Aktie (IRMD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	18.26%24.20	20.47	21.98	22.69	21.20
Cost Of Revenue	8.31%5.75	5.31	5.17	5.66	4.71
Gross Profit	21.74%18.46	15.16	16.81	17.03	16.49
	17.65%10.32	8.77	9.58	9.94	9.66
Research and Development	33.18%0.88	0.66	0.96	0.80	0.67
Operating Income/Loss	27.35%8.14	6.39	7.24	7.09	6.83
Nonoperating Income/Loss	6.44%0.53	0.50	0.53	0.70	0.46
Income/Loss From Continuing Operations Before Tax	25.84%8.67	6.89	7.77	7.79	7.30
Income Tax Expense/Benefit	29.46%2.16	1.67	1.95	1.35	1.72
	24.68%6.51	5.22	5.82	6.44	5.58
Attributable To Parent	24.68%6.51	5.22	5.82	6.44	5.58
Basic Average Shares	0.02%12.79	12.78	12.78	0.01	12.72
Diluted Average Shares	0.03%12.88	12.87	12.87	0.01	12.86
Basic Earnings Per Share	24.39%0.51	0.41	0.46	0.51	0.44
Diluted Earnings Per Share	24.39%0.51	0.41	0.45	0.50	0.43